PP
IOVA icon

PDT Partners’s Iovance Biotherapeutics IOVA Stock Holding History

PDT Partners’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-216,880
Closed -$1.39M – 644
2022
Q4 		$1.39M Buy
216,880
+9,955
+5% +$77.7K 0.22% 154
2022
Q3 		$1.98M Buy
206,925
+191,276
+1,222% +$2.21M 0.3% 71
2022
Q2 		$173K Buy
+15,649
New +$205K 0.02% 842
2021
Q2 		– Sell
-17,030
Closed -$539K – 882
2021
Q1 		$539K Buy
+17,030
New +$706K 0.04% 493
2015
Q3 		– Sell
-68,814
Closed -$631K – 1409
2015
Q2 		$631K Buy
+68,814
New +$768K 0.02% 900

Other funds holding IOVA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return